Publications by authors named "Hongming Yu"

Claim this Profile
A
Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study.
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Yi-Tao Zheng, Yun-Feng Shan

J Hepatocell Carcinoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
Min Li, Xuxiao He, Weixing Guo, Hongming Yu, Shicheng Zhang, Yufu Tang, Yujuan Zhuo, Yu Li, Jiang Yue

Nat Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Validation, and Subtype Analysis of a Predictive Model for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
Ailian Shen, Jing Xu, Qiucang Xue, Hongming Yu, Jing Liang, Xiuzheng Yue, Yuying Liu

Rev Cardiovasc Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial.
Kang Wang, Jinkai Feng, Hongming Yu, Yuqiang Cheng, Yanjun Xiang, Enyu Liu, Yunfeng Shan, Yufu Tang, Luowen Yu

Signal Transduct Target Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of artificial intelligence-based quantitative CT feature analysis for diagnosing the pathological types of pulmonary nodules.
Haoyuan Zhang, Kun Liu, Yadong Ding, Hanbo Li, Jing Liang, Hongming Yu

Eur Radiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of clinical characteristics and related risk factors of patients with Clostridioides difficile infection in the intensive care unit].
Hongming Yu, Qinfu Liu, Shenglin Su, Gang Li, Xiaojun Yang

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.
Yan-Jun Xiang, Kang Wang, Ying-Yi Qin, Zong-Han Liu, Hong-Ming Yu, Yu-Qiang Cheng, Yu-Fu Tang, Yun-Feng Shan

Eur J Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two types of double chambered left ventricle: a case series.
Aijuan Fang, Lei Liu, Hui Chen, Xiuling Ma, Hongming Yu

Eur Heart J Case Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance assessment of an artificial intelligence-based coronary artery calcium scoring algorithm in non-gated chest CT scans of different slice thickness.
Kejie Yin, Wenping Chen, Guochu Qin, Jing Liang, Xue Bao, Hongming Yu, Yujie Wang

Quant Imaging Med Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new scoring system for predicting the outcome of hepatocellular carcinoma patients without microvascular invasion-a large-scale multicentre study.
Ju-Xian Sun, Zhe Yang, Jia-Yi Wu, Jie Shi, Hong-Ming Yu

HPB (Oxford)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated detection and classification of coronary atherosclerotic plaques on coronary CT angiography using deep learning algorithm.
Jing Liang, Kefeng Zhou, Michael P Chu, Yujie Wang, Gang Yang, Hongming Yu

Quant Imaging Med Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu

Nat Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Yun-Feng Shan

BMC Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linearly polarized fiber amplifier with narrow linewidth of 5 kW exhibiting a record output power and near-diffraction-limited beam quality.
Yanshan Wang, Wanjing Peng, Hang Liu, Xiaobo Yang, Hongming Yu, Yujun Feng

Opt Lett· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Jinghan Wang, Hongming Yu, Wei Dong, Cheng Zhang, Mingtai Hu, Hengyu Li

Gastroenterology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.
Wei-Jun Wang, Zong-Han Liu, Kang Wang, Hong-Ming Yu, Yu-Qiang Cheng

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.
Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni

Future Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-led iodinated contrast media infusion risk assessment service.
Huiyan Jiang, Yuan Li, Xiaoyan Wu, Hongming Yu, Xin Zhang

Front Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study.
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yanjun Xiang, Zhenyu Zhu

J Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Kang Wang, Zong-Han Liu, Hong-Ming Yu, Yu-Qiang Cheng, Yan-Jun Xiang

Therap Adv Gastroenterol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol.
Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni

BMJ Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy.
Kang Wang, Yanjun Xiang, Jiangpeng Yan, Yuyao Zhu, Hanbo Chen, Hongming Yu, Yuqiang Cheng

Hepatol Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.
Kang Wang, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni

Future Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iodine-based extracellular volume for evaluating myocardial status in patients undergoing percutaneous coronary intervention for acute myocardial infarction by using dual-layer spectral detector computed tomography: a comparison study with magnetic resonance.
Jing Liang, Hui Li, Jun Xie, Hongming Yu, Wenping Chen

Quant Imaging Med Surg· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis